The Mobilise App Lab IPO is a closed SME Bookbuilding offer (Fresh Capital) that opened on 23 February 2026. The Mobilise App Lab IPO closed on 25 February 2026, with an issue price of ₹80 per share. The Mobilise App Lab IPO has a face value of ₹10 and a lot size of 1,600 shares. The Mobilise App Lab IPO is listed on 2 March 2026. The Mobilise App Lab IPO allotment was scheduled for 26 February 2026.
On the financial front, the Mobilise App Lab IPO reported revenue of ₹14 crore for 31 Dec 2025, compared with ₹16 crore for 31 Mar 2025. The Mobilise App Lab IPO PAT was ₹4 crore against ₹5 crore. The Mobilise App Lab IPO EBITDA stood at ₹6 crore with a 48.34% margin. The Mobilise App Lab IPO net worth as of 31 Dec 2025 was ₹12 crore.
Always verify The Mobilise App Lab IPO details and GMP data with the official offer document before investing in the Mobilise App Lab IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Dec 2025
31 Mar 2025
31 Mar 2024
Total Assets
16
12
7
Revenue
14
16
12
PAT
4
5
3
EBITDA
6
7
4
Net Worth
12
8
4
Reserves
5
6
4
Total Borrowing
0
0
0
Mobilise App Lab IPO Financials FAQs
Revenue of Mobilise App Lab (Amount in ₹ Crore) — 31 Dec 2025: 14; 31 Mar 2025: 16; 31 Mar 2024: 12. Profit after tax (PAT) — 31 Dec 2025: 4; 31 Mar 2025: 5; 31 Mar 2024: 3.
EBITDA of Mobilise App Lab (Amount in ₹ Crore) — 31 Dec 2025: 6; 31 Mar 2025: 7; 31 Mar 2024: 4. The EBITDA margin is 48.34%.
Total assets — 31 Dec 2025: 16; 31 Mar 2025: 12; 31 Mar 2024: 7. Net worth — 31 Dec 2025: 12; 31 Mar 2025: 8; 31 Mar 2024: 4. Reserves & surplus — 31 Dec 2025: 5; 31 Mar 2025: 6; 31 Mar 2024: 4. (Amount in ₹ Crore)
Total borrowing of Mobilise App Lab (Amount in ₹ Crore) — 31 Dec 2025: 0; 31 Mar 2025: 0; 31 Mar 2024: 0. Debt-to-equity ratio: 0.02.
The financials shown for Mobilise App Lab IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
